VOLUME 18 | NUMBER 9 | SEPTEMBER 2015 nature neurOSCIenCe a r t I C l e S Evidence of the importance of epigenetic mechanisms underlying complex neuronal processes, including learning and memory, is rapidly emerging [1][2][3][4] . Thus, neuron-specific alternative splicing events affecting the histone modification machinery have become an intriguing potential molecular mechanism for the epigenetic control of neuronal gene transcriptional programs involved in synaptic plasticity and cognition. LSD1 (also known as KDM1A) was initially described as a cofactor of the REST-CoREST complex 5, 6 and was reported to harbor intrinsic enzymatic activity for removing mono-or dimethyl lysine on histone H3 K4 and, in specific circumstances, H3 K9, respectively 7, 8 . Although LSD1 can function as a co-repressor of specific transcription factors, such as REST, by removing H3K4 methylation on gene promoters and enhancers, it also has been reported to function as a coactivator of specific transcription factors by removing H3K9 methylation, suggesting that its intrinsic substrate specificity determines its biological function on transcription regulation [7] [8] [9] [10] . Recently, a neuronal splicing variant of Lsd1 was identified that is dynamically expressed during mammalian brain development and regulates neurite morphogenesis 11 . This initial report suggested that the alternatively spliced Lsd1 isoform in neurons has distinct biological functions compared with its canonical form, even though it adopts a similar structure as the canonical LSD1 in association with CoREST and a histone H3 peptide 11 .
a r t I C l e S
Evidence of the importance of epigenetic mechanisms underlying complex neuronal processes, including learning and memory, is rapidly emerging [1] [2] [3] [4] . Thus, neuron-specific alternative splicing events affecting the histone modification machinery have become an intriguing potential molecular mechanism for the epigenetic control of neuronal gene transcriptional programs involved in synaptic plasticity and cognition. LSD1 (also known as KDM1A) was initially described as a cofactor of the REST-CoREST complex 5, 6 and was reported to harbor intrinsic enzymatic activity for removing mono-or dimethyl lysine on histone H3 K4 and, in specific circumstances, H3 K9, respectively 7, 8 . Although LSD1 can function as a co-repressor of specific transcription factors, such as REST, by removing H3K4 methylation on gene promoters and enhancers, it also has been reported to function as a coactivator of specific transcription factors by removing H3K9 methylation, suggesting that its intrinsic substrate specificity determines its biological function on transcription regulation [7] [8] [9] [10] . Recently, a neuronal splicing variant of Lsd1 was identified that is dynamically expressed during mammalian brain development and regulates neurite morphogenesis 11 . This initial report suggested that the alternatively spliced Lsd1 isoform in neurons has distinct biological functions compared with its canonical form, even though it adopts a similar structure as the canonical LSD1 in association with CoREST and a histone H3 peptide 11 .
We investigated the role of the neuronal-specific splicing variant of Lsd1 (Lsd1n) in the regulation of neuronal gene expression programs and in the cognitive functions of learning and memory by generating a conditional knockout (KO) mouse model with a specific Lsd1n deletion. In this study, we documented impaired transcriptional response to neuronal activity with defects in both initiation and elongation steps in the Lsd1n KO cortical neurons. In addition, behavioral analysis of Lsd1n KO mice revealed an essential role for Lsd1n for spatial learning and long-term memory formation. Notably, the neuron-specific alternatively spliced isoform of LSD1 exhibited a previously unknown substrate specificity for histone H4 K20 methylation, suggesting that neuronal-specific alternative splicing events underlie the epigenetic regulation of learning and memory processes.
RESULTS

LSD1n functions as a histone H4 K20 methylase in vitro
The alternatively spliced exons occur in intron 2 and in intron 8, resulting in the inclusion of a 60-nucleotide (nt) exon in intron 2 (E2a), which is ubiquitously expressed, or a 12-nt exon in intron 8 (E8a), which is observed exclusively in neurons ( Fig. 1a and Supplementary Fig. 1a ) 11 . We refer to Lsd1 without E8a inclusion as Lsd1c (canonical form, which includes Lsd1 and Lsd1-E2a), and to Lsd1 with E8a inclusion as Lsd1n (neuronal form, which includes Lsd1-E8a and Lsd1-E2a + E8a). Using mouse embryonic stem (ES) cell as a model of in vitro differentiation, we found that Lsd1n was absent in undifferentiated ES cells, but was highly expressed following retinoid acid-induced ES cell differentiation toward neuronal lineages (Supplementary Fig. 1b) . Sequence analysis non-mammalian vertebrates revealed that similar alternative splicing events were present in turtle and fish, in which four or six amino acids were included following exon inclusion (Supplementary Fig. 1c) , indicating a r t I C l e S that the alternative splicing of Lsd1 gene is conserved during evolution. Because the Lsd1n splicing variant has distinct biological functions compared with its canonical form 11 , we were intrigued as to whether this variant exhibits distinct enzymatic activity toward novel substrates. We performed in vitro demethylase assays using recombinant LSD1c and LSD1n proteins purified from bacterial cells 2,000 0 LSD1 peak center (promoter) -2,000 2,000 0 LSD1 peak center (promoter) -2,000 2,000 0 LSD1 peak center (enhancer) -2,000 2,000 0 LSD1 peak center (enhancer) -2,000 2,000 0 LSD1 peak center (promoter) -2,000 2,000 0 LSD1 peak center (enhancer) -2,000 2,000 0 LSD1 peak center (enhancer) -2,000 2,000 0 LSD1 peak center (promoter) -2,000 2,000 0 LSD1 peak center (promoter) -2,000 2,000 0 LSD1 peak center (enhancer) -2,000 2,000 0 LSD1 peak center (enhancer) (b) Histone demethylase assay in vitro using nucleosomes as substrates. Shown is a western blot analysis using antibodies against histone marks revealing removal of H4K20 methylation by LSD1n and increased in presence of CoREST. The amount of protein was quantified on the basis of the intensity of the bands using ImageJ software; the 2× control had an arbitrarily assigned value of 100. (c) Venn diagram showing the genome-wide overlap of ChIP-seq peaks of LSD1 in primary cortical neurons before and after KCl-mediated depolarization (1 h). A, C and D sites indicate promoters and B, D and F indicate enhancers shown in d. (d) LSD1 genome occupancy in cortical neurons was changed after KCl-mediated depolarization. Heat maps show LSD1 (total), FLAG-LSD1c, FLAG-LSD1n and H4K20me1 genome occupancies before and after KCl treatment (1 h) in cortical neurons, centered on LSD1 peaks before KCl treatment and divided into four groups based on c. An additional 3 kb from the center of the peaks is shown. (e) Histogram plots of normalized ChIP-seq tag intensities of LSD1, H3K4me1, H3K4me2, H3K9me2, H3K36me3 and H4K20me1 in cortical neurons, centered on gained LSD1 peaks at promoters and enhancers before and after KCl treatment (1 h). An additional 2 kb from the center of the peaks is shown. (f) UCSC genome browser image of Npas4 locus, revealing overlapping MEF2 and LSD1 peaks. Full-length gel and blot images can be found in Supplementary Figure 10 . npg a r t I C l e S (Supplementary Fig. 1d ). When using core histones as substrates, although LSD1c showed an H3 K4 demethylase activity as expected, recombinant LSD1n lost its intrinsic activity toward H3 K4 methylation, but gained a specific demethylase activity toward histone H4 K20 (Supplementary Fig. 1e ). In support of our hypothesis that LSD1n specifically removes H4 K20 methylation, we found that none of the major methylation sites on histone H3 could be used as a substrate (Supplementary Fig. 1e) . Moreover, when the lysine 685 in the catalytic domain of LSD1n was mutated (LSD1m, K685A mutant), the demethylase activity toward H4 K20 was lost ( Supplementary  Fig. 1f,g ), implying that LSD1n also uses a FAD-dependent mechanism to remove mono-and di-methylation on lysine in vitro, as previously reported 7 . Similar H4K20 demethylase activity was observed when nucleosomes were used as substrates in a CoREST-dependent fashion (Fig. 1b) . To further characterize the enzymatic activity of LSD1n, we used H3K4me1, H3K4me2, H3K9me1, H3K9me2, H4K20me1 and H4K20me2 peptides as substrates in the in vitro demethylase assays ( Supplementary Fig. 2a-c) . LSD1n removed methylations on H3K4me1 and H3K4me2 peptides after we added recombinant CoREST, although not as robustly as LSD1c ( Supplementary  Fig. 2a ), in accordance with previously reported H3K4 demethylase activity of LSD1n on histone peptides 11 . However, even in the presence of CoREST, the H3K4 demethylase activity of LSD1n was not observed on substrates of core histones or nucleosomes ( Fig. 1b  and Supplementary Fig. 1e) . In similar experiments, neither LSD1n nor LSD1c could demethylate the H3K9me1 or H3K9me2 peptides (Supplementary Fig. 2b ). Furthermore, we found that LSD1n, but not LSD1m or LSD1c, removed the methyl group from the H4K20me1 and H4K20me2 peptides, although not as robustly as observed on core histones (Supplementary Fig. 2c ), indicating that histone peptides are not as effective as core histones for LSD1n as substrates. In addition, we found that both LSD1c and LSD1n interacted with histone H3 or H4 tails in vitro (Supplementary Fig. 3a,b) , whereas CoREST interacted with H4 tail (Supplementary Fig. 3c ). We further mapped the CoREST-H4 interaction region to the N-terminal ELM2 domain of CoREST (Supplementary Fig. 3d,e) , which has been identified in many chromatin-associated proteins, although its function is largely unknown. These observations suggest that CoREST enhances LSD1n enzymatic activity through direct interaction with histone H4. Because LSD1n can demethylate H4K20 on a truncated histone H4 peptide (H4 aa10-30), we speculate that it may adopt a different conformation than the previously reported structure of LSD1n/CoREST complexed with the N-terminal of histone H3 tail 11 . New conformations of LSD1 have been suggested when LSD1 removes methylation on non-histone substrates such as p53 (ref. 12).
Our finding that purified LSD1n was incapable of H3K4 or H3K9 demethylation is consistent with a recent report that LSD1n can mediate H3K9me2 demethylation only in association with Supervilincontaining complex in differentiated neuronal cell lines 13 . These results emphasize the importance of uncovering the global genomic distribution of the distinct LSD1 isoforms in neurons.
LSD1 occupies gene promoters and enhancers LSD1 has been reported to regulate gene expression by occupying active gene promoters and enhancers 9, 14 , and functions as an enhancer 'decommissioner' during ES cell differentiation 14 . However, its roles in differentiated neurons remain relatively unexplored. To identify which genes are direct targets of LSD1c or LSD1n, we performed genomewide mapping experiments using chromatin immunoprecipitation coupled with deep sequencing (ChIP-seq) in mouse cortical neurons using an antibody that recognizes total LSD1. Using a standard KCl-mediated depolarization protocol to mimic neuronal activity stimulation 15 , we identified 11,218 and 12,701 LSD1-binding sites in primary cortical neurons in resting and active states, respectively, of which 5,471 were common binding sites under both conditions (Fig. 1c) . LSD1 binding sites were enriched on gene promoters and enhancers, consistent with previously published LSD1 genome-wide localization analyses 9, 14 . To distinguish LSD1n from LSD1c, we generated Lsd1c and Lsd1n transgenic mice, which express FLAG-tagged isoform-specific Lsd1 following tamoxifen-induced Cre-mediated recombination (Supplementary Fig. 4a ). The expression levels of the specific FLAG-tagged isoforms of LSD1 in transgenic mice were similar to the levels in wild-type (WT) mice (Supplementary Fig. 4b) . We observed similar genome-localization of LSD1c and LSD1n in ChIP-seq experiments using FLAG antibody to specifically detect each isoform, indicating that the recruitment of LSD1 was not isoform specific ( Fig. 1d and Supplementary Fig. 4c,d) . Notably, we observed a decreased level of H4K20me1 on signal-dependent LSD1-binding sites at promoters and enhancers after KCl-mediated depolarization ( Fig. 1d,e) , without substantial changes of other histone marks, except for a slightly increased level of H3K4me1 on those LSD1-binding promoters, as determined by meta-analysis of ChIP-seq experiments (Fig. 1e) . These data suggest that the recruitment of LSD1 correlates with specific removal of H4K20 methylation in a genome-wide fashion. In addition, we observed that neurons overexpressing Lsd1n exhibited a decreased global level of H4K20 methylation ( Supplementary  Fig. 4e ), consistent with the observation of LSD1n-dependent H4K20 demethylation activity in vitro.
To explore which transcription factors might recruit LSD1 to these sites, we performed de novo sequence motif analyses using the HOMER software package 16 . We found that CTCF or CTCF-like Boris recognition motifs were specifically enriched in enhancer sites where LSD1 occupancy was lost after KCl-mediated depolarization ( Supplementary Fig. 4f ). Conversely, MEF2 binding motifs were specifically enriched in LSD1-bound enhancer sites gained after depolarization ( Supplementary Fig. 4g ), whereas CREB binding motifs were specifically enriched in gained LSD1-bound promoter sites ( Supplementary Fig. 4h ). This result suggests that LSD1 may target enhancer and promoter elements regulated by transcription factors MEF2 and CREB, which are known to be crucial for neuronal activity-regulated gene transcription 17 . Indeed, immunoprecipitation assays revealed that LSD1 could form a complex with both MEF2 and CREB ( Supplementary Fig. 4i ), supporting the idea that LSD1 might function as a co-regulator of these transcription factors. Furthermore, genome-wide mapping of MEF2 by ChIP-seq confirmed that both LSD1 and MEF2 occupy a subset of neuronal enhancers ( Supplementary Fig. 4j-l) 17 . Specifically, 4,482 of 5,320 (84%) gained LSD1-occupied enhancers were also bound by MEF2 ( Supplementary Fig. 4j ), suggesting that MEF2 might recruit LSD1 to these enhancer sites. Consistent with this prediction, depolarization-induced recruitment of LSD1 was observed on known enhancer elements regulated by MEF2, including those in the Npas4, Arc and Egr1 loci ( Fig. 1f and Supplementary Fig. 4m,n) . These data suggest a regulatory role of LSD1 on the neuronal activity-regulated genes.
LSD1n controls neuronal activity-regulated gene expression
To investigate the in vivo role of LSD1n in transcriptional control, we initially performed global transcriptional profiling analysis by RNAseq using a conditional KO model of LSD1, in which both Lsd1c and Lsd1n were deleted following Cre-mediated recombination 10 . Primary cortical neurons were cultured for 10 d in vitro before KCl-mediated depolarization (6 h). We found that KCl-induced gene transcription npg a r t I C l e S was largely compromised in cortical neurons following Lsd1 deletion ( Supplementary Fig. 5a ), providing initial evidence that LSD1 is involved in the regulation of neuronal activity-regulated gene transcription. To assess the extent by which LSD1n contributes to this regulatory mechanism, we generated a conditional KO mouse model targeting Lsd1n (Fig. 2a) . Following Nestin-Cre-mediated recombination, the Lsd1n conditional KO mice expressed Lsd1c only, whereas wild-type (WT) control mice expressed Lsd1n as the dominant form in cortical neurons (Supplementary Fig. 5b) , and the total level of LSD1 appeared to be unchanged ( Supplementary Fig. 5b,c) . Using this strategy, we performed global transcriptional profiling experiments by RNA-seq in cortical neurons isolated from E15.5 embryos of Lsd1n KO or WT control mice. RNA-seq analysis revealed that 454 genes were upregulated following 6 h of KCl-mediated depolarization in WT neurons ( Supplementary  Fig. 5d ) and that Lsd1n-deficient cortical neurons exhibited an impaired transcriptional response ( Supplementary Fig. 5d ), suggesting that LSD1n was indispensable for the neuronal activity-regulated gene expression. To determine whether LSD1n regulates gene expression at the transcriptional or post-transcriptional level, we performed global run-on coupled with deep-sequencing analysis (GRO-seq) 18 , which enabled us to directly measure transcriptional events. Analysis of the GRO-seq experiments revealed that 1,548 genes were upregulated after 1 h of KCl-mediated depolarization in WT control neurons (Fig. 2b,c) . The transcriptional response was substantially impaired in Lsd1n-deficient cortical neurons (Fig. 2b,c) . For example, transcription of Npas4, which encodes a critical neuronal activity-regulated transcription factor 19 , was Chr19: npg a r t I C l e S upregulated following KCl treatment in WT neurons, whereas its activation was compromised in Lsd1n-deficient neurons (Fig. 2d) . Similar results were observed for other neuronal activity-regulated genes, such as Arc and Egr1 (Supplementary Fig. 5e ,f), and were validated by real-time quantitative PCR (RT-qPCR; Fig. 2e ). It has been reported that some of neuronal activity-regulated enhancers express non-coding RNAs, called eRNAs 15, 20 . We found that expression of KCl-induced eRNAs, such as eRNAs from enhancers of Arc, Fos, Npas4 and Nr4a1 loci (Supplementary Fig. 5g ), were decreased in Lsd1n-deficient neurons, as measured by RT-qPCR ( Supplementary Fig. 5h) , suggesting a regulatory role of LSD1n on enhancer activity. In addition, LSD1n was bound to the promoters of the majority of neuronal activity-regulated genes, as shown by LSD1n ChIP-seq (Supplementary Fig. 5i ), suggesting that LSD1n regulates gene expression by binding to promoters and enhancers of its target genes.
LSD1n removes histone H4 K20 methylation in vivo
To determine the causality between LSD1n-dependent transcriptional changes and histone demethylation, we performed H3K4me1, H3K9me2, H3K36me3 and H4K20me1 ChIP-seq experiments using WT or Lsd1n-deficient neurons. Although the levels of H3K4me1, H3K9me2 or H3K36me3 were not substantially changed at LSD1-binding sites at promoters or enhancers in Lsd1n-deficient cortical neurons, as determined by meta-analysis of ChIP-seq experiments ( Supplementary Fig. 6a-c) , the H4K20 methylation levels were substantially increased at LSD1-bound promoters and enhancers in a genome-wide fashion (Supplementary Fig. 6d ). This is consistent with our initial result showing that LSD1n can function in vitro as a H4K20 demethylase (Fig. 1b) . Furthermore, we observed no substantial changes or slight decrease of other histone methylation markers, including H3K4me2, H3K9me2 and H3K79me2, on promoters of LSD1n gene targets, including Naps4 and Arc ( Supplementary  Fig. 6e-g ), consistent with our hypothesis that LSD1n specifically targets H4K20me1, but not other methylated histone substrates. Further analysis of H4K20me1ChIP-seq revealed that this histone mark was substantially increased at transcribed coding regions of neuronal activity-regulated genes (Fig. 3a) that were Lsd1n-dependent (Fig. 2b,c) , consistent with a repressive role of H4K20me1 on gene expression. Supporting the idea of a direct effect of Lsd1n deletion on H4K20 methylation, we observed that the global H4K20 methylation levels were increased in Lsd1n-deficient neurons (Supplementary Fig. 6h ), but reduced in Lsd1n-overexpressing neurons ( Supplementary  Fig. 4e ). These results strongly support our finding that LSD1n can remove the H4K20 methylation mark in vivo. Furthermore, the expression level of known H4K20 methyltransferases (Pr-Set7/Setd8, Suv420h1, Suv420h2) 21, 22 and demethylases (Phf8, Phf2) [23] [24] [25] was not substantially changed in Lsd1n-deficient neurons (RNA-seq and GRO-seq experiments), except for a slight increase of PHF8 proteins (Supplementary Fig. 6h ), supporting our conclusion of a direct role of LSD1n as a H4K20 demethylase in cortical neurons. Furthermore, we noticed that the expression level of Phf8 was low in cortical neurons in which Lsd1n was abundant (Supplementary Fig. 6i ). Consistent with these data, shRNA-mediated downregulation of Phf8 did not alter the KCl-induced transcriptional response of LSD1n target genes (Supplementary Fig. 6j,k) , suggesting that LSD1n, but not PHF8, mediates the H4K20 demethylation events in response to neuronal activity in vivo.
We investigated the possibility that LSD1n may utilize both H3K9 and H4K20 methylated substrates to activate gene expression in cortical neurons, which is particularly intriguing given that LSD1n can mediate H3K9me2 demethylation in association with Supervilin (Svil)-containing complex 13 during differentiation protocols. However, we do not observe substantial changes in H3K9me2 levels at LSD1n-binding sites at promoters or enhancers in cortical neurons (Supplementary Fig. 6b,f) . Instead, we found increased H4K20me1 levels on those targets (Fig. 3a and Supplementary Fig. 6d ). Because Svil expression has been reported to be transiently induced following neuronal differentiation in a human neuroblastoma cell line 13 , we determined the expression level of Svil in mouse cortical neurons. Using validated primer sets and RNA-seq results, we found that Svil expression was extremely low in cortical neurons compared with the levels of Lsd1 (Supplementary Fig. 6i) , suggesting that Svil-dependent H3K9 demethylation may not be involved in LSD1n-dependent transcriptional control in cortical neurons.
LSD1n promotes transcriptional initiation and elongation
The finding that H4K20me1 levels were high across transcribed coding regions, consistent with a previous report 26 , suggests that LSD1n might regulate elongation. To test this hypothesis, we performed RNA polymerase II (Pol II) ChIP-seq experiments using WT control or Lsd1n-deficient neurons. Analysis of RNA Pol II genome-wide distribution revealed that KCl-mediated depolarization led to an induction of both transcriptional elongation and initiation steps, as shown by the increased RNA Pol II signals on the transcription start sites (TSS) and transcribed coding regions of neuronal activity-regulated genes, including Npas4 (Fig. 3b) , Arc and Egr1 (Supplementary Fig. 7a,b) . To examine the global effect of LSD1n on elongation, we calculated the RNA Pol II traveling ratio (TR) of neuronal activity-regulated genes, as determined by our RNA Pol II ChIP-seq experiments, which revealed a statistically significant shift of RNA Pol II signals (increased pausing) in Lsd1n-deficient neurons compared with WT controls (Fig. 3c,d) , supporting the hypothesis that LSD1n is involved in the regulation of elongation in a genome-wide fashion. We further confirmed these results by analyzing the TR using our GRO-seq experiments, comparing WT and Lsd1n-deficient neurons after KClmediated depolarization (Supplementary Fig. 7c ). To further validate the roles of LSD1n on transcription initiation and/or elongation steps, we analyzed RNA Pol II binding at the TSS and across the transcribed coding regions of KCl depolarization-induced transcription units, including Arc, Egr1 and Npas4. Because RNA Pol II density over transcribed coding regions was dependent on initiation and elongation steps, RNA Pol II density ratio between the 3′ region (coding region) and the 5′ region (TSS) can serve as a surrogate index for RNA Pol II pause-release status. In this analysis, higher values indicate increased release, and lower values indicate increased pausing. The RNA Pol II intensity on Npas4 TSS (measured by 5′ PCR probe) was significantly increased in WT neurons 1 h after KCl-mediated depolarization, but this effect was compromised in Lsd1n-deficient neurons (Fig. 3e) , suggesting that the transcription initiation of Npas4 gene was compromised in the Lsd1n-deficient neurons. Simultaneously, RNA Pol II density across the Npas4 coding region (measured by 3′ PCR probe) was increased in WT neurons after KCl treatment, but was compromised in Lsd1n-deficient neurons (Fig. 3f) . Furthermore, we observed that, in WT control neurons, the RNA Pol II 3′/5′ ratio for Npas4 gene was increased after treatment, indicating that KCl-mediated depolarization had a greater effect on the elongation step compared with the initiation step; this effect was reduced in the Lsd1n-deficient neurons, indicating that LSD1n is involved in transcriptional elongation control (Fig. 3g) . Similarly, transcription elongation of Arc and Egr1 were also compromised in Lsd1n-deficient neurons, as measured by RNA Pol II ChIP (Supplementary Fig. 7d-i) . a r t I C l e S Our findings are consistent with a previous report demonstrating that Arc gene expression is regulated by promoter-proximal RNA Pol II stalling after neuronal activity stimulation 27 . We confirmed this observation in our genome-wide analysis ( Fig. 3d and Supplementary  Fig. 7j ). We found that this mechanism was LSD1n dependent (Fig. 3c,d and Supplementary Fig. 7c) . A similar promoterproximal RNA Pol II pause/release regulation has also been reported for genes induced following TLR4-mediated gene activation 28 , suggesting that elongation control is important for signal-dependent trancription 29 .
Because H4K20me1 has been reported to inhibit CBP/p300 histone acetyltransferase activity toward H4K16Ac in vitro 21 , we examined whether the increased level of H4K20me1 that we observed in Lsd1n-deficient neurons might affect H4K16Ac in vivo. We found decreased levels of H4K16Ac at promoters of Lsd1n target genes, such as Npas4 and Arc (Supplementary Fig. 7k ). This observation correlates with the increased levels of L3MBTL1 ( Supplementary  Fig. 7l ), an H4K20me1 reader 30 , and the decreased recruitment of Brd4 (Supplementary Fig. 7m ), a reader of histone acetylation and a critical regulator of transcriptional elongation 31 npg a r t I C l e S we found that the levels of H3K36me3, a histone marker associated with elongation 26 , were decreased at transcribed coding regions of neuronal activity-regulated genes in Lsd1n KO neurons (Fig. 3h) , but not on LSD1-binding sites at promoters or enhancers ( Supplementary  Fig. 6c ), indicating that Lsd1n deficiency causes a defect in transcriptional elongation of neuronal activity-regulated genes. In addition, we observed increased recruitment of LSD1n at the transcribed coding regions of neuronal activity-regulated genes after KCl-mediated depolarization ( Supplementary Fig. 7n-p) , suggesting that LSD1n promotes neuronal activity-regulated transcriptional elongation by removing H4K20 methylation in transcribed coding regions.
LSD1n is required for spatial learning and memory Because LSD1n is required for regulated gene expression induced by neuronal activity, which regulates its genomic localization, we hypothesize that LSD1n might be critical for learning and memory. Thus, we analyzed the behavioral phenotype of the brain-specific Lsd1n KO mice. Lsd1n KO mice survived to adulthood and showed no obvious anatomical abnormality (Supplementary Fig. 8a ). In addition, Lsd1n-deficient mice showed normal activity in the optomotor and locomotor activity tests (Supplementary Fig. 8b,e) , indicating that Lsd1n-deficient mice have normal vision and movement abilities, permitting the use of behavioral assessment experiments to determine the roles of LSD1n in learning and memory. To this aim, we used a set of standard behavioral tasks assessing spatial learning and memory, which have been previously linked to mechanisms of neuronal activity-regulated gene transcription 32 . Although Lsd1n KO mice did not show any impairment in the Y maze spontaneous alternation test, which measures simple working memory (Supplementary Fig. 8c,d) , we observed cognitive deficits when the Barnes maze test was performed using sex-and age-matched WT control and Lsd1n KO mice (Fig. 4a) . Although WT control mice identified the target quadrant relative to the other non-target quadrants of the maze, Lsd1n KO mice failed to identify the target after training (Fig. 4a) , indicating that Lsd1n KO mice have impaired spatial learning. In addition, Lsd1n KO mice showed significant impairments in performing the novel object recognition task. Indeed, Lsd1n KO mice failed to distinguish novel objects from familiar objects in this behavioral task (Fig. 4b,c) , indicating that Lsd1n was required for recognition memory. Although it has been reported that Lsd1 is important for circadian rhythmicity 33 , Lsd1n KO mice appeared to have normal motor activities when tested in dark and light cycles (Supplementary Fig. 8e ), suggesting that Lsd1n is not required for this behavior. To examine the extent to which LSD1n-dependent transcriptional regulation is correlated with the defects in learning and memory, we measured the expression level of neuronal activity-regulated genes, including Arc, Btg2, Egr1 and Npas4. We observed that the expression of these genes was decreased in Lsd1n KO mice compared with their WT littermate controls (Fig. 4d) . In addition, Lsd1n KO mice exhibited increased levels of H4K20 methylation ( Supplementary  Fig. 8f) , consistent with our observations that LSD1n has an active role as a histone H4K20 mono-and dimethyl demethylase in cortical neurons (Supplementary Fig. 6h) .
It has been documented for more than 40 years that histone H4K20 methylation levels increase in aged rat brain 34 and that histone H4K20me3 level increase in quiescence and senescence 35 . We found that Lsd1n levels were decreased, whereas total levels of Lsd1 transcript were almost unchanged, in aged mice ( Supplementary  Fig. 8g,h ). It will be interesting to determine whether the decreased expression of Lsd1n contributes to the age-related H4K20me level increases and cognitive impairments, such as memory loss.
Taken together, we found that an alternative splicing event occurring only in neurons switches the enzymatic demethylase activity of LSD1 from histone H3K4 to histone H4K20 methylated substrates 
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WT KO Lsd1n WT Lsd1n KO T a r g e t q u a d r a n t O t h e r q u a d r a n t s T a r g e t q u a d r a n t O t h e r q u a d r a n t s npg a r t I C l e S in post-mitotic cortical neurons, and that this unique isoform of LSD1 promotes neuronal activity-regulated gene expression, facilitating both transcription initiation and elongation steps. This was essential for spatial learning and long-term memory formation (Supplementary Fig. 9 ).
DISCUSSION
Given that LSD1n can mediate H3K9me2 demethylation in association with Supervilin-containing complex during neuronal differentiation events 13 , it is possible that both H3K9 and H4K20 demethylase activities of LSD1n contribute to its brain functions. Notably, it has been reported that the deficiency of G9a/Glp, the major H3K9 methyltransferases for H3K9me2, can induce de-repression of a subset of genes involved in neuronal differentiation 36, 37 . Thus, it is likely that LSD1n-dependent H4K20 demethylation is linked to transcriptional events that are essential for learning and memory, whereas its H3K9 demethylase function is required for gene expression during neuronal differentiation. Although CoREST enhances LSD1n-dependent H4K20 demethylation in vitro, CoREST/Rcor1 was not required for LSD1n function in neurons, as CoREST/Rcor1 KO mice had normal brain functions (personal communications, G. Mandel). However, Rcor1/Rcor2 double KO mice were embryonic lethal, revealing similar phenotype with total Lsd1 KO mice (data not shown and personal communication, G. Mandel). It is possible that Rcor2, a homolog of CoREST/Rcor1, can compensate functions of CoREST in vivo. It is interesting that CoREST complex contains both HDAC1/2 and LSD1, given that HDAC1/2 and LSD1 have distinct function in neuronal gene expression regulation. It will be an interesting topic to investigate in the future.
Given that LSD1 is not only located at promoters and transcribed coding regions, and that high enrichment is also observed at enhancers elements, we cannot exclude that LSD1-bound enhancers are involved in regulating neuronal gene expression ( Supplementary  Figs. 5i and 7n-p) . It is possible that promoter-enhancer looping may act as a mechanism for delivering LSD1n from distal enhancers to promoters and transcribed coding regions to remove negative H4K20me1 mark. eRNAs expression could also contribute to neuronal activity-dependent gene expression, as recently reported 20, 38 , and we hypothesize that LSD1n may regulate eRNA expression in a fashion that is mechanistically similar to that of the regulation of protein-coding genes, enhancing transcription elongation by facilitating H4K16 acetylation and Brd4 recruitment and/or inhibiting L 3 MBTL1 recruitment.
H4K20 methylation is the major lysine methylation site on histone H4, and is involved in cell cycle regulation, DNA damage response, mitotic chromatin condensation and transcription regulation 39 . However, the effect of H4K20me1 on transcriptional control and brain function is poorly understood. Our data suggest that H4K20me1 serves as a negative regulator of gene expression/elongation, which is signal dependent, and is associated with neuronal-specific events. PHF8 deficiency has been linked to mental retardation 40 ; however, it is not clear whether the defects observed are a result of cell cycle regulatory functions of PHF8. The characterization of LSD1n reveals the important role of H4K20 methylation on transcription elongation control and cognitive functions such as spatial learning and memory.
One cannot help but speculate about why this unique alternative splicing event of LSD1 occurs specifically in neurons. There are at least two non-mutually exclusive possibilities. First, neurons could require this demethylase to maintain proper H4K20 methylation level, as they have lost the ability to reset H4K20 methylation state by cell cycle-dependent histone mark deposition, which would appropriately methylate newly incorporated histones. Second, H4K20 methylation could serve as a marker for regulating transcription in post-mitotic neurons, where it is not required for cell cycle control. Neurons might have acquired this enzymatically unique isoform to remove H4K20me1/2 and achieve more precise control of gene expression in complex processes such as learning and memory.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. The RNA-seq, GRO-seq and ChIP-seq data sets were deposited at the Gene Expression Omnibus (GEO) under the subseries entry GSE63271. The NCBI GEO accession number for MEF2 ChIP-seq data set is GSE66710. defined from ChIP-seq. Peak sequences were compared to random genomic fragments of the same size and normalized G/C content to identify motifs enriched in the ChIP-seq targeted sequence. To generate histograms for the average distribution of tag densities, position-corrected, normalized tags in 50 bp windows were tabulated within the indicated distance from specific sites in the genome. Clustering plots for normalized tag densities at each genomic region were generated using HOMER and then clustered using Cluster (http:// bonsai.hgc.jp/~mdehoon/software/cluster/software.htm) and visualized using Java TreeView, as described 48 .
To determine LSD1-binding active enhancers, putative enhancers sites were first defined based on ChIP-seq enrichment of H3K4me1 flanking ±1,000 bp from the center of the LSD1 peaks. Putative enhancers were defined by the following criteria: (1) regions were at least 3 kb away from annotated TSSs; (2) regions had at least 16 tags from H3K4me1 ChIP-seq normalized to 10,000,000 tags; and (3) regions had at least ten tags from GRO-seq normalized to 10,000,000 tags.
genome-wide gene expression analysis with gRo-seq. GRO-seq analysis of genome-wide gene expression was performed by HOMER followed by edgeR 16, 49 . Briefly, HOMER was used to generate a gene expression matrix by identifying uniquely mapped RNA tags to gene body; that is, from 500bp downstream of TSS to 13 kb the annotated end if gene body is shorter than 13 kb, based on RefSeq annotation for the mouse genome (mm9). Statistical analysis for differential expression was performed using edgeR on raw sequencing reads from neurons that were treated with or without KCl. To identify the different expressed genes that were governed by Lsd1n, cultured cortical neurons were incubated for 0, 1 or 3 h and then used for GRO-seq experiments. All six GRO-seqs were normalized to 10,000,000 tags, and HOMER was used to quantify gene expression by tabulating normalized RPKM value for the gene body of each gene. Genes with a >1.5-fold change in GRO-seq signal was considered to be differentially expressed. tR calculation. TR calculation was performed as described 50 . TR was defined as the relative ratio of RNA Pol II density in the promoter-proximal region and the gene body. The promoter proximal region refers to the window from −50 bp to +300 bp surrounding TSS. The significance of the change of TR between wild type and Lsd1n KO samples was calculated using two-tailed KolmogorovSmirnov test.
Statistics.
No statistical methods were used to pre-determine sample sizes but our sample sizes are similar to those generally employed in the field. No randomization and blinding were employed. Data distribution was assumed to be normal but this was not formally tested. There was correction for multiple comparisons. No animals or data points were excluded from analyses.
The P value, degree of freedom and t value are calculated using on-line tools from http://www.graphpad.com/quickcalcs/ttest1.cfm. The exact P values are reported in the figure legends; the degree of freedom T, D and F values are calculated as follows. 
